Collagen–biomaterial for drug delivery

W Friess - European journal of pharmaceutics and …, 1998 - Elsevier
The use of collagen as a biomaterial is currently undergoing a renaissance in the tissue
engineering field. The biotechnological applications focus on the aspects of cellular growth or …

The freezing step in lyophilization: Physico-chemical fundamentals, freezing methods and consequences on process performance and quality attributes of …

JC Kasper, W Friess - European journal of pharmaceutics and …, 2011 - Elsevier
Lyophilization is a common, but cost-intensive, drying process to achieve protein formulations
with long-term stability. In the past, typical process optimization has focused on the drying …

Recent advances and further challenges in lyophilization

JC Kasper, G Winter, W Friess - European Journal of Pharmaceutics and …, 2013 - Elsevier
While entering a new century, lyophilization in the pharmaceutical field has been subjected
to ongoing development and steady expansion. This review aims to highlight recent …

Collagen as a carrier for on-site delivery of antibacterial drugs

Z Ruszczak, W Friess - Advanced drug delivery reviews, 2003 - Elsevier
Due to its biocompatibility and well-established safety profile, collagen represents a
favourable matrix for on-site drug delivery. In this review, we summarize some of the recent …

Shaken, not stirred: mechanical stress testing of an IgG1 antibody

S Kiese, A Papppenberger, W Friess… - Journal of pharmaceutical …, 2008 - Elsevier
Protein aggregation is known to occur under different stress conditions and displays a wide
variety of morphologies. In this work, the aggregation behavior of a monoclonal antibody (…

Impact of freezing procedure and annealing on the physico-chemical properties and the formation of mannitol hydrate in mannitol–sucrose–NaCl formulations

A Hawe, W Frieß - European journal of pharmaceutics and …, 2006 - Elsevier
The goal was to investigate the impact of NaCl on the physico-chemical properties of
mannitol–sucrose formulations during freezing and drying, with special focus on mannitol hydrate …

Protein aggregation: pathways, induction factors and analysis

HC Mahler, W Friess, U Grauschopf, S Kiese - Journal of pharmaceutical …, 2009 - Elsevier
Control and analysis of protein aggregation is an increasing challenge to pharmaceutical
research and development. Due to the nature of protein interactions, protein aggregation may …

Particles in therapeutic protein formulations, Part 1: Overview of analytical methods

…, M Wiggenhorn, G Winter, W Jiskoot, W Friess… - Journal of …, 2012 - Elsevier
The presence of particles is a major issue during therapeutic protein formulation development.
Both proteinaceous and nonproteinaceous particles need to be analyzed not only due to …

Advancing therapeutic protein discovery and development through comprehensive computational and biophysical characterization

L Gentiluomo, HL Svilenov, D Augustijn… - Molecular …, 2019 - ACS Publications
Therapeutic protein candidates should exhibit favorable properties that render them suitable
to become drugs. Nevertheless, there are no well-established guidelines for the efficient …

[HTML][HTML] N-glycosylation heterogeneity and the influence on structure, function and pharmacokinetics of monoclonal antibodies and Fc fusion proteins

F Higel, A Seidl, F Sörgel, W Friess - European journal of pharmaceutics …, 2016 - Elsevier
Monoclonal antibody and Fc fusion protein drugs are complex heterogeneous mixtures of
numerous different protein variants and modifications. N-glycosylation as one of the most …